Mesoblast (MESO) Equity Average: 2015-2024
Historic Equity Average for Mesoblast (MESO) over the last 8 years, with Dec 2024 value amounting to $470.8 million.
- Mesoblast's Equity Average fell 6.82% to $470.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $470.8 million, marking a year-over-year decrease of 6.82%. This contributed to the annual value of $491.1 million for FY2024, which is 1.67% down from last year.
- As of Q4 2024, Mesoblast's Equity Average stood at $470.8 million, which was down 4.80% from $494.5 million recorded in Q2 2024.
- Mesoblast's 5-year Equity Average high stood at $591.2 million for Q2 2021, and its period low was $470.8 million during Q4 2024.
- Over the past 3 years, Mesoblast's median Equity Average value was $505.3 million (recorded in 2023), while the average stood at $500.9 million.
- As far as peak fluctuations go, Mesoblast's Equity Average rose by 14.00% in 2021, and later dropped by 14.22% in 2022.
- Over the past 5 years, Mesoblast's Equity Average (Quarterly) stood at $528.6 million in 2020, then increased by 3.60% to $547.6 million in 2021, then dropped by 6.61% to $511.4 million in 2022, then declined by 1.20% to $505.3 million in 2023, then dropped by 6.82% to $470.8 million in 2024.
- Its Equity Average was $470.8 million in Q4 2024, compared to $494.5 million in Q2 2024 and $505.3 million in Q4 2023.